文献速递瓣膜病与结构性心脏病心律失常

经导管主动脉瓣植入术后新发心律失常的系统评价与荟萃分析

New-onset arrhythmias following transcatheter aortic valve implantation: a systematic review and meta-analysis.
PubMed 文献 · Heart · 2017-12-23

新发房颤最常见,汇总患病率在院内、30天、1年和2年随访分别为11%、14%、14%和25%(趋势P=0.011),且增加死亡(RR 1.61)和脑血管事件(RR 1.79)风险。

要点

  • TAVI术后新发房颤常见,2年汇总患病率达25%。
  • 新发房颤与死亡风险(RR 1.61)和脑血管事件风险(RR 1.79)增加相关。
  • 多数研究仅监测术后第一个月的心律失常,监测策略报告不足。

核心结论

  • TAVI术后新发心律失常的系统识别可能对患者后续治疗管理和长期预后产生重要影响。

主要发现

  • 新发房颤(2641例)是最常记录的心律失常,汇总患病率在院内、30天、1年和2年随访分别为11%、14%、14%和25%(趋势P=0.011)。
  • 30天随访时新发房颤汇总患病率在前瞻性与回顾性研究间差异显著(8% vs 21%,P=0.002)。
  • 1年随访新发缓慢性心律失常汇总粗患病率为4%。
  • 新发房颤增加死亡风险(RR 1.61,95%CI 1.35-1.98,I2=47%)和脑血管事件风险(RR 1.79,95%CI 1.24-2.64,I2=0%)。

临床怎么用

  • TAVI术后应系统监测新发心律失常,尤其新发房颤,以识别高风险患者并指导治疗管理。

局限性

  • 仅31项研究(48%)明确说明心律失常检测方法。
  • 多数研究(52/65)新发心律失常检测仅限于术后第一个月。
  • 无研究报道检测到新发心律失常后的治疗调整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the prevalence and clinical impact of new-onset arrhythmias in patients following transcatheter aortic valve implantation (TAVI). METHOD: We systematically identified studies reporting new-onset arrhythmias after TAVI other than atrioventricular conduction disturbances. We summarised monitoring strategies, type and prevalence of arrhythmias and estimated their effect on risk of death or cerebrovascular events by using random-effects meta-analysis. The study is registered withInternational prospective register of systematic reviews (PROSPERO) (CRD42017058053). RESULTS: Sixty-five studies (43 506 patients) reported new-onset arrhythmias following TAVI. The method of arrhythmia detection was specified only in 31 studies (48%). New-onset atrial fibrillation (NOAF) (2641 patients), bradyarrhythmias (182 patients), supraventricular arrhythmias (29 patients), ventricular arrhythmias (28 patients) and non-specified major arrhythmias (855 patients) were reported. In most studies (52 out of 65), new-onset arrhythmia detection was limited to the first month following TAVI. The most frequently documented arrhythmia was NOAF with trend of increasing summary prevalence of 11%, 14%, 14% and 25% during inhospital, 30-day, 1-year and 2-year follow-ups, respectively (P for trend=0.011). Summary prevalence estimates of NOAF at 30-day follow-up differ significantly between studies of prospective and retrospective design (8% and 21%, respectively, P=0.002). New episodes of bradyarrhythmias were documented with a summary crude prevalence of 4% at 1-year follow-up. NOAF increased the risk of death (relative risk 1.61, 95% CI 1.35 to 1.98, I2=47%) and cerebrovascular events (1.79, 95% CI 1.24 to 2.64, I2=0%). No study commented on therapeutic modifications following the detection of new-onset arrhythmias. CONCLUSIONS: Systematic identification of new-onset arrhythmias following TAVI may have considerable impact on subsequent therapeutic management and long-term prognosis in this patient population.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Siontis GCM, Praz F, Lanz J, et al. New-onset arrhythmias following transcatheter aortic valve implantation: a systematic review and meta-analysis. Heart. 2017. PMID: 29275399. doi:10.1136/heartjnl-2017-312310

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。